Innovid Corp. (CTV) Misses Q3 EPS by 4c; Offers Guidance

Innovid Corp. (NYSE: CTV) reported Q3 EPS of ($0.09), $0.04 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $34.5 million versus the consensus estimate of $36.5 million.

GUIDANCE:

Innovid Corp. sees Q4 2022 revenue of $34-36 million, versus the consensus of $36.933 million.

Innovid Corp. sees FY2022 revenue of $127-129 million, versus the consensus of $129.9 million.

For earnings history and earnings-related data on Innovid Corp. (CTV) click here.

You May Also Be Interested In

• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c
• Cheetah Net Supply Chain Service Inc. (CTNT) Reports Q2 EPS of $0.04